Fingerprint
Dive into the research topics of 'Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically